1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Viral Conjunctivitis Drugs Market Size Growth Rate by Type: 2020 VS 2026 1.2.2 FST-100 1.2.3 APD-209 1.3 Market by Application 1.3.1 Global Viral Conjunctivitis Drugs Market Share by Application: 2020 VS 2026 1.3.2 Hospitals 1.3.3 ASCs 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Viral Conjunctivitis Drugs Market Perspective (2015-2026) 2.2 Global Viral Conjunctivitis Drugs Growth Trends by Regions 2.2.1 Viral Conjunctivitis Drugs Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Viral Conjunctivitis Drugs Historic Market Share by Regions (2015-2020) 2.2.3 Viral Conjunctivitis Drugs Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Viral Conjunctivitis Drugs Players by Market Size 3.1.1 Global Top Viral Conjunctivitis Drugs Players by Revenue (2015-2020) 3.1.2 Global Viral Conjunctivitis Drugs Revenue Market Share by Players (2015-2020) 3.2 Global Viral Conjunctivitis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Viral Conjunctivitis Drugs Revenue 3.4 Global Viral Conjunctivitis Drugs Market Concentration Ratio 3.4.1 Global Viral Conjunctivitis Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Viral Conjunctivitis Drugs Revenue in 2019 3.5 Key Players Viral Conjunctivitis Drugs Area Served 3.6 Key Players Viral Conjunctivitis Drugs Product Solution and Service 3.7 Date of Enter into Viral Conjunctivitis Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Viral Conjunctivitis Drugs Breakdown Data by Type (2015-2026) 4.1 Global Viral Conjunctivitis Drugs Historic Market Size by Type (2015-2020) 4.2 Global Viral Conjunctivitis Drugs Forecasted Market Size by Type (2021-2026) 5 Viral Conjunctivitis Drugs Breakdown Data by Application (2015-2026) 5.1 Global Viral Conjunctivitis Drugs Historic Market Size by Application (2015-2020) 5.2 Global Viral Conjunctivitis Drugs Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Viral Conjunctivitis Drugs Market Size (2015-2026) 6.2 North America Viral Conjunctivitis Drugs Market Size by Type (2015-2020) 6.3 North America Viral Conjunctivitis Drugs Market Size by Application (2015-2020) 6.4 North America Viral Conjunctivitis Drugs Market Size by Country (2015-2020) 6.4.1 United States 6.4.2 Canada 7 Europe 7.1 Europe Viral Conjunctivitis Drugs Market Size (2015-2026) 7.2 Europe Viral Conjunctivitis Drugs Market Size by Type (2015-2020) 7.3 Europe Viral Conjunctivitis Drugs Market Size by Application (2015-2020) 7.4 Europe Viral Conjunctivitis Drugs Market Size by Country (2015-2020) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 7.4.6 Nordic 7.4.7 Rest of Europe 8 China 8.1 China Viral Conjunctivitis Drugs Market Size (2015-2026) 8.2 China Viral Conjunctivitis Drugs Market Size by Type (2015-2020) 8.3 China Viral Conjunctivitis Drugs Market Size by Application (2015-2020) 8.4 China Viral Conjunctivitis Drugs Market Size by Region (2015-2020) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 Southeast Asia 8.4.5 India 8.4.6 Australia 8.4.7 Rest of Asia-Pacific 9 Japan 9.1 Japan Viral Conjunctivitis Drugs Market Size (2015-2026) 9.2 Japan Viral Conjunctivitis Drugs Market Size by Type (2015-2020) 9.3 Japan Viral Conjunctivitis Drugs Market Size by Application (2015-2020) 9.4 Japan Viral Conjunctivitis Drugs Market Size by Country (2015-2020) 9.4.1 Mexico 9.4.2 Brazil 10 Southeast Asia 10.1 Southeast Asia Viral Conjunctivitis Drugs Market Size (2015-2026) 10.2 Southeast Asia Viral Conjunctivitis Drugs Market Size by Type (2015-2020) 10.3 Southeast Asia Viral Conjunctivitis Drugs Market Size by Application (2015-2020) 10.4 Southeast Asia Viral Conjunctivitis Drugs Market Size by Country (2015-2020) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 UAE 10.4.4 Rest of Middle East & Africa 11 Key Players Profiles 11.1 Adenovir Pharma 11.1.1 Adenovir Pharma Company Details 11.1.2 Adenovir Pharma Business Overview 11.1.3 Adenovir Pharma Viral Conjunctivitis Drugs Introduction 11.1.4 Adenovir Pharma Revenue in Viral Conjunctivitis Drugs Business (2015-2020)) 11.1.5 Adenovir Pharma Recent Development 11.2 Allergan 11.2.1 Allergan Company Details 11.2.2 Allergan Business Overview 11.2.3 Allergan Viral Conjunctivitis Drugs Introduction 11.2.4 Allergan Revenue in Viral Conjunctivitis Drugs Business (2015-2020) 11.2.5 Allergan Recent Development 11.3 NanoViricides 11.3.1 NanoViricides Company Details 11.3.2 NanoViricides Business Overview 11.3.3 NanoViricides Viral Conjunctivitis Drugs Introduction 11.3.4 NanoViricides Revenue in Viral Conjunctivitis Drugs Business (2015-2020) 11.3.5 NanoViricides Recent Development 11.4 Takeda 11.4.1 Takeda Company Details 11.4.2 Takeda Business Overview 11.4.3 Takeda Viral Conjunctivitis Drugs Introduction 11.4.4 Takeda Revenue in Viral Conjunctivitis Drugs Business (2015-2020) 11.4.5 Takeda Recent Development 11.5 NovaBay Pharmaceuticals 11.5.1 NovaBay Pharmaceuticals Company Details 11.5.2 NovaBay Pharmaceuticals Business Overview 11.5.3 NovaBay Pharmaceuticals Viral Conjunctivitis Drugs Introduction 11.5.4 NovaBay Pharmaceuticals Revenue in Viral Conjunctivitis Drugs Business (2015-2020) 11.5.5 NovaBay Pharmaceuticals Recent Development 11.6 Novartis 11.6.1 Novartis Company Details 11.6.2 Novartis Business Overview 11.6.3 Novartis Viral Conjunctivitis Drugs Introduction 11.6.4 Novartis Revenue in Viral Conjunctivitis Drugs Business (2015-2020) 11.6.5 Novartis Recent Development 11.7 Panoptes Pharma 11.7.1 Panoptes Pharma Company Details 11.7.2 Panoptes Pharma Business Overview 11.7.3 Panoptes Pharma Viral Conjunctivitis Drugs Introduction 11.7.4 Panoptes Pharma Revenue in Viral Conjunctivitis Drugs Business (2015-2020) 11.7.5 Panoptes Pharma Recent Development 11.8 NicOx 11.8.1 NicOx Company Details 11.8.2 NicOx Business Overview 11.8.3 NicOx Viral Conjunctivitis Drugs Introduction 11.8.4 NicOx Revenue in Viral Conjunctivitis Drugs Business (2015-2020) 11.8.5 NicOx Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Viral Conjunctivitis Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 3. Key Players of FST-100 Table 4. Key Players of APD-209 Table 5. Global Viral Conjunctivitis Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 6. Global Viral Conjunctivitis Drugs Market Size by Regions (US$ Million): 2020 VS 2026 Table 7. Global Viral Conjunctivitis Drugs Market Size by Regions (2015-2020) (US$ Million) Table 8. Global Viral Conjunctivitis Drugs Market Share by Regions (2015-2020) Table 9. Global Viral Conjunctivitis Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 10. Global Viral Conjunctivitis Drugs Market Share by Regions (2021-2026) Table 11. Viral Conjunctivitis Drugs Market Market Trends Table 12. Viral Conjunctivitis Drugs Market Drivers Table 13. Viral Conjunctivitis Drugs Market Challenges Table 14. Viral Conjunctivitis Drugs Market Restraints Table 15. Global Viral Conjunctivitis Drugs Revenue by Players (2015-2020) (US$ Million) Table 16. Global Viral Conjunctivitis Drugs Market Share by Players (2015-2020) Table 17. Global Top Viral Conjunctivitis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Conjunctivitis Drugs as of 2019) Table 18. Global Viral Conjunctivitis Drugs by Players Market Concentration Ratio (CR5 and HHI) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Viral Conjunctivitis Drugs Product Solution and Service Table 21. Mergers & Acquisitions, Expansion Plans Table 22. Global Viral Conjunctivitis Drugs Market Size by Type (2015-2020) (US$ Million) Table 23. Global Viral Conjunctivitis Drugs Market Size Share by Type (2015-2020) Table 24. Global Viral Conjunctivitis Drugs Revenue Market Share by Type (2021-2026) Table 25. Global Viral Conjunctivitis Drugs Market Size Share by Application (2015-2020) Table 26. Global Viral Conjunctivitis Drugs Market Size by Application (2015-2020) (US$ Million) Table 27. Global Viral Conjunctivitis Drugs Market Size Share by Application (2021-2026) Table 28. North America Viral Conjunctivitis Drugs Market Size by Type (2015-2020) (US$ Million) Table 29. North America Viral Conjunctivitis Drugs Market Share by Type (2015-2020) Table 30. North America Viral Conjunctivitis Drugs Market Size by Application (2015-2020) (US$ Million) Table 31. North America Viral Conjunctivitis Drugs Market Share by Application (2015-2020) Table 32. North America Viral Conjunctivitis Drugs Market Size by Country (US$ Million) (2015-2020) Table 33. North America Viral Conjunctivitis Drugs Market Share by Country (2015-2020) Table 34. Europe Viral Conjunctivitis Drugs Market Size by Type (2015-2020) (US$ Million) Table 35. Europe Viral Conjunctivitis Drugs Market Share by Type (2015-2020) Table 36. Europe Viral Conjunctivitis Drugs Market Size by Application (2015-2020) (US$ Million) Table 37. Europe Viral Conjunctivitis Drugs Market Share by Application (2015-2020) Table 38. Europe Viral Conjunctivitis Drugs Market Size by Country (US$ Million) (2015-2020) Table 39. Europe Viral Conjunctivitis Drugs Market Share by Country (2015-2020) Table 40. China Viral Conjunctivitis Drugs Market Size by Type (2015-2020) (US$ Million) Table 41. China Viral Conjunctivitis Drugs Market Share by Type (2015-2020) Table 42. China Viral Conjunctivitis Drugs Market Size by Application (2015-2020) (US$ Million) Table 43. China Viral Conjunctivitis Drugs Market Share by Application (2015-2020) Table 44. China Viral Conjunctivitis Drugs Market Size by Region (US$ Million) (2015-2020) Table 45. China Viral Conjunctivitis Drugs Market Share by Region (2015-2020) Table 46. Japan Viral Conjunctivitis Drugs Market Size by Type (2015-2020) (US$ Million) Table 47. Japan Viral Conjunctivitis Drugs Market Share by Type (2015-2020) Table 48. Japan Viral Conjunctivitis Drugs Market Size by Application (2015-2020) (US$ Million) Table 49. Japan Viral Conjunctivitis Drugs Market Share by Application (2015-2020) Table 50. Japan Viral Conjunctivitis Drugs Market Size by Country (US$ Million) (2015-2020) Table 51. Japan Viral Conjunctivitis Drugs Market Share by Country (2015-2020) Table 52. Southeast Asia Viral Conjunctivitis Drugs Market Size by Type (2015-2020) (US$ Million) Table 53. Southeast Asia Viral Conjunctivitis Drugs Market Share by Type (2015-2020) Table 54. Southeast Asia Viral Conjunctivitis Drugs Market Size by Application (2015-2020) (US$ Million) Table 55. Southeast Asia Viral Conjunctivitis Drugs Market Share by Application (2015-2020) Table 56. Southeast Asia Viral Conjunctivitis Drugs Market Size by Country (US$ Million) (2015-2020) Table 57. Southeast Asia Viral Conjunctivitis Drugs Market Share by Country (2015-2020) Table 58. Adenovir Pharma Company Details Table 59. Adenovir Pharma Business Overview Table 60. Adenovir Pharma Product Table 61. Adenovir Pharma Revenue in Viral Conjunctivitis Drugs Business (2015-2020) (US$ Million) Table 62. Adenovir Pharma Recent Development Table 63. Allergan Company Details Table 64. Allergan Business Overview Table 65. Allergan Product Table 66. Allergan Revenue in Viral Conjunctivitis Drugs Business (2015-2020) (US$ Million) Table 67. Allergan Recent Development Table 68. NanoViricides Company Details Table 69. NanoViricides Business Overview Table 70. NanoViricides Product Table 71. NanoViricides Revenue in Viral Conjunctivitis Drugs Business (2015-2020) (US$ Million) Table 72. NanoViricides Recent Development Table 73. Takeda Company Details Table 74. Takeda Business Overview Table 75. Takeda Product Table 76. Takeda Revenue in Viral Conjunctivitis Drugs Business (2015-2020) (US$ Million) Table 77. Takeda Recent Development Table 78. NovaBay Pharmaceuticals Company Details Table 79. NovaBay Pharmaceuticals Business Overview Table 80. NovaBay Pharmaceuticals Product Table 81. NovaBay Pharmaceuticals Revenue in Viral Conjunctivitis Drugs Business (2015-2020) (US$ Million) Table 82. NovaBay Pharmaceuticals Recent Development Table 83. Novartis Company Details Table 84. Novartis Business Overview Table 85. Novartis Product Table 86. Novartis Revenue in Viral Conjunctivitis Drugs Business (2015-2020) (US$ Million) Table 87. Novartis Recent Development Table 88. Panoptes Pharma Company Details Table 89. Panoptes Pharma Business Overview Table 90. Panoptes Pharma Product Table 91. Panoptes Pharma Revenue in Viral Conjunctivitis Drugs Business (2015-2020) (US$ Million) Table 92. Panoptes Pharma Recent Development Table 93. NicOx Business Overview Table 94. NicOx Product Table 95. NicOx Company Details Table 96. NicOx Revenue in Viral Conjunctivitis Drugs Business (2015-2020) (US$ Million) Table 97. NicOx Recent Development Table 98. Research Programs/Design for This Report Table 99. Key Data Information from Secondary Sources Table 100. Key Data Information from Primary Sources List of Figures Figure 1. Global Viral Conjunctivitis Drugs Market Share by Type: 2020 VS 2026 Figure 2. FST-100 Features Figure 3. APD-209 Features Figure 4. Global Viral Conjunctivitis Drugs Market Share by Application: 2020 VS 2026 Figure 5. Hospitals Case Studies Figure 6. ASCs Case Studies Figure 7. Viral Conjunctivitis Drugs Report Years Considered Figure 8. Global Viral Conjunctivitis Drugs Market Size (US$ Million), YoY Growth 2015-2026 Figure 9. Global Viral Conjunctivitis Drugs Market Share by Regions: 2020 VS 2026 Figure 10. Global Viral Conjunctivitis Drugs Market Share by Regions (2021-2026) Figure 11. Global Viral Conjunctivitis Drugs Market Share by Players in 2019 Figure 12. Global Top Viral Conjunctivitis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Conjunctivitis Drugs as of 2019 Figure 13. The Top 10 and 5 Players Market Share by Viral Conjunctivitis Drugs Revenue in 2019 Figure 14. North America Viral Conjunctivitis Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 15. United States Viral Conjunctivitis Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 16. Canada Viral Conjunctivitis Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 17. Europe Viral Conjunctivitis Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 18. Germany Viral Conjunctivitis Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 19. France Viral Conjunctivitis Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 20. U.K. Viral Conjunctivitis Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 21. Italy Viral Conjunctivitis Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 22. Russia Viral Conjunctivitis Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 23. Nordic Viral Conjunctivitis Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 24. Rest of Europe Viral Conjunctivitis Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. Asia-Pacific Viral Conjunctivitis Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. China Viral Conjunctivitis Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. Japan Viral Conjunctivitis Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. South Korea Viral Conjunctivitis Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. Southeast Asia Viral Conjunctivitis Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. India Viral Conjunctivitis Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. Australia Viral Conjunctivitis Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. Rest of Asia-Pacific Viral Conjunctivitis Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. Latin America Viral Conjunctivitis Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. Mexico Viral Conjunctivitis Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. Brazil Viral Conjunctivitis Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. Middle East & Africa Viral Conjunctivitis Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. Turkey Viral Conjunctivitis Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. Saudi Arabia Viral Conjunctivitis Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. UAE Viral Conjunctivitis Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. Rest of Middle East & Africa Viral Conjunctivitis Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. Adenovir Pharma Revenue Growth Rate in Viral Conjunctivitis Drugs Business (2015-2020) Figure 42. Allergan Revenue Growth Rate in Viral Conjunctivitis Drugs Business (2015-2020) Figure 43. NanoViricides Revenue Growth Rate in Viral Conjunctivitis Drugs Business (2015-2020) Figure 44. Takeda Revenue Growth Rate in Viral Conjunctivitis Drugs Business (2015-2020) Figure 45. NovaBay Pharmaceuticals Revenue Growth Rate in Viral Conjunctivitis Drugs Business (2015-2020) Figure 46. Novartis Revenue Growth Rate in Viral Conjunctivitis Drugs Business (2015-2020) Figure 47. Panoptes Pharma Revenue Growth Rate in Viral Conjunctivitis Drugs Business (2015-2020) Figure 48. NicOx Revenue Growth Rate in Viral Conjunctivitis Drugs Business (2015-2020) Figure 49. Bottom-up and Top-down Approaches for This Report Figure 50. Data Triangulation Figure 51. Key Executives Interviewed

Adenovir Pharma Allergan NanoViricides Takeda NovaBay Pharmaceuticals Novartis Panoptes Pharma NicOx